CDMO — Avid Bioservices Cashflow Statement
0.000.00%
Last trade - 00:00
- $466.58m
- $585.55m
- $149.27m
- 50
- 41
- 52
- 45
2019 April 30th | 2020 April 30th | 2021 April 30th | 2022 April 30th | 2023 April 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -4.21 | -10.5 | 11.2 | 128 | 0.56 |
Depreciation | |||||
Deferred Taxes | |||||
Non-Cash Items | -3.83 | 2.51 | 4.77 | 8.79 | 12.2 |
Discontinued Operations | |||||
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -6.3 | 10.7 | 11.7 | -16.4 | -34.3 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | -11.6 | 5.83 | 31.2 | 9.46 | -12.9 |
Capital Expenditures | -1.5 | -3.81 | -9.86 | -56.4 | -77.6 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 6.05 | 0 | 0 | — | — |
Sale of Fixed Assets | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | 4.54 | -3.81 | -9.86 | -56.4 | -77.6 |
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -2.86 | 1.1 | 112 | 3.2 | 2.9 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -9.91 | 3.11 | 134 | -43.7 | -87.6 |